S0309, Repository: Blood/Bone Marrow From Pts. With Myeloma, WM, Amyloidosis, or MGUS.
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT00919139|
Recruitment Status : Completed
First Posted : June 12, 2009
Last Update Posted : April 3, 2015
RATIONALE: Collecting and storing samples of blood and bone marrow from patients with cancer to study in the laboratory may help doctors find better ways to ways to treat the cancer.
PURPOSE: The purpose of this study is to collect and store blood and bone marrow samples from patients with multiple myeloma, smoldering myeloma, Waldenstrom's macroglobulinemia, amyloidosis, and monoclonal gammopathy of undetermined significance to be tested in the laboratory.
|Condition or disease||Intervention/treatment|
|Multiple Myeloma Smoldering Myeloma Waldenstrom's Macroglobulinemia Monoclonal Gammopathy of Undetermined Significance Amyloidosis||Other: biologic sample preservation procedure|
- Maintain and expand tissue repositories of myeloma specimens from uniformly treated Southwest Oncology Group (SWOG) patients with multiple myeloma, smoldering myeloma, Waldenstrom's macroglobulinemia, amyloidosis, or monoclonal gammopathy of undetermined significance.
- Utilize scientific information generated from intergroup and collaborative studies to assist the SWOG Myeloma Committee in the development of new and more effective treatment regimens for these patients.
OUTLINE: Patients receive treatment as directed by the treatment protocols on which they are registered. Specimens of blood and/or marrow are submitted to the Myeloma Repository. The status of the patient (e.g., pre-study, post-remission, or relapse) will be recorded prior to specimen collection.
PROJECTED ACCRUAL: Not specified
|Study Type :||Observational|
|Actual Enrollment :||190 participants|
|Official Title:||S0309, Myeloma Specimen Repository Protocol, Ancillary|
|Study Start Date :||November 2003|
|Actual Primary Completion Date :||November 2010|
|Actual Study Completion Date :||November 2010|
Other: biologic sample preservation procedure
- Maintenance and expansion of tissue repositories of myeloma specimens from uniformly treated SWOG patients with multiple myeloma, smoldering myeloma, Waldenstrom's macroglobulinemia, amyloidosis, or monoclonal gammopathy of undetermined significance [ Time Frame: 7 years ]
- Development of new and more effective treatment regimens for these patients using scientific information generated from intergroup and collaborative studies [ Time Frame: 7 years ]
Biospecimen Retention: Samples With DNA
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00919139
Show 207 Study Locations
|Study Chair:||Joshua Espstein, DSC||University of Arkansas|